Back to Top Skip to main content

Awards honor distinguished service, individual and team research

Pictured are the recipients of the 2018 MHSRS Awards, including the 2018 MHSRS Distinguished Service Award, the individual achievement in research awards, and the research team awards. Right to left are Air Force Maj. Joseph K. Maddry, Army Col. Michael P. Kozar, Kenneth M. Hargreaves, DDS, Ph.D., Navy Lt. Cmdr. Micah Gaspary, Australian Defence Force Col. Michael Reade, Army Col. Andrew P. Cap, Dr. Thomas Joiner and Dr. Peter Gutierrez. (MHS photo) Pictured are the recipients of the 2018 MHSRS Awards, including the 2018 MHSRS Distinguished Service Award, the individual achievement in research awards, and the research team awards. Right to left are Air Force Maj. Joseph K. Maddry, Army Col. Michael P. Kozar, Kenneth M. Hargreaves, DDS, Ph.D., Navy Lt. Cmdr. Micah Gaspary, Australian Defence Force Col. Michael Reade, Army Col. Andrew P. Cap, Dr. Thomas Joiner and Dr. Peter Gutierrez. (MHS photo)

Recommended Content:

MHSRS 2019 | Research and Innovation

KISSIMMEE, Fla. — Military research accomplishments were recognized on Monday, the opening day of the Military Health System Research Symposium at the Gaylord Palms Resort and Convention Center in Kissimmee, Florida. Three individuals and four teams were honored.

Army Col. Michael Kozar, director of the Military Infectious Diseases Research Program, received the 2018 MHSRS Distinguished Service Award for lifetime achievement in the research category of military infectious diseases.

Dr. Kelley Brix, branch chief of interagency research coordination at the Defense Health Agency, said Kozar has demonstrated outstanding leadership in pursuit of excellence.

“Col. Kozar’s experience at all levels of clinical and research laboratory operations, as well as the military acquisition system, allowed him to foster the development of globally effective countermeasures to combat critical infectious diseases,” said Brix, moderator of the awards presentation. “He’s also nurtured the development of infectious disease subject matter experts who will continue to serve future generations of warfighters.”

The Australian Red Cross Blood Service, Australian Defence Force, and Clinical Laboratory Improvement Program investigators won the Outstanding Research Team/Small Team/Academia-Industry Award (research category: blood and blood products).Col. Michael Reade, team co-lead, accepted on behalf of the group, which completed a 121-patient, four-hospital trial of cryopreserved platelets. Their efforts doubled the clinical trial evidence supporting use of this technology, and set the conditions needed for the next step toward regulatory approval. (MHS photo)
The Australian Red Cross Blood Service, Australian Defence Force, and Clinical Laboratory Improvement Program investigators won the Outstanding Research Team/Small Team/Academia-Industry Award (research category: blood and blood products).Col. Michael Reade, team co-lead, accepted on behalf of the group, which completed a 121-patient, four-hospital trial of cryopreserved platelets. Their efforts doubled the clinical trial evidence supporting use of this technology, and set the conditions needed for the next step toward regulatory approval. (MHS photo)

Army Col. Andrew Cap, with the U.S. Army Institute of Surgical Research in San Antonio, received the award for outstanding individual research accomplishment/military (research category: blood and blood products).

“Col. Cap has led the DoD’s research and development efforts for blood products used to treat combat casualties, resulting in several innovations that have transformed battlefield medicine and which have been adopted for the care of civilian patients,” Brix said.

Kenneth Hargreaves, from the University of Texas Health Science Center in San Antonio, received the award for outstanding individual research accomplishment/academia-industry (research category: pain management). Brix called Hargreaves an active leader in a DoD-National Institutes of Health federal pain consortium involving six research projects and over 25 collaborating investigators from military, VA, and civilian academic institutions.

His research “has had a significant impact on science, public health, and bettering the lives of military service members,” Brix said.

The recipients of the 2018 MHSRS Team Awards are as follows:

Outstanding Research Team/Small Team/Military: Enroute Care to the U.S. Air Force Enroute Care Research Center, San Antonio (research category: enroute care).  

Maj. Joseph Maddry, team lead, accepted on behalf of the group, who initiated a process improvement that increased management compliance of mechnically ventillated critical care air transport team patients from 38 percent to 80 percent. Their findings also led to the development of a clinical practice guideline.

Outstanding Research Team/Large Team/Military: Combat Trauma Research Group, Naval Medical Center Portsmouth, Virginia (research category: combat casualty care).

Lt. Cmdr. Micah Gaspary, team lead, accepted on behalf of the group, which completed studies that directly influenced and supported changes in the Committee on Tactical Combat Casualty Care’s official guidelines. Also, “The team has single-handedly changed the culture at Naval Medical Center Portsmouth with their enthusiastic approach to pursuing research,” Brix said.

Outstanding Research Team/Small Team/Academia-Industry:  Australian Red Cross Blood Service, Australian Defence Force, and Clinical Laboratory Improvement Program investigators (research category: blood and blood products).

Col. Michael Reade, team co-lead, accepted on behalf of the group, which completed a 121-patient, four-hospital trial of cryopreserved platelets. Their efforts doubled the clinical trial evidence supporting use of this technology, and set the conditions needed for the next step toward regulatory approval, Brix said.

Outstanding Research Team/Large Team/Academia-Industry: Military Suicide Research Consortium (research category: psychological health).

Dr. Peter Gutierrez and Dr. Thomas Joiner, co-directors, accepted for the group’s work with academic, DoD and VA partners to focus cutting-edge science on the issue of suicides in the U.S. military. Since the consortium’s establishment in 2010, Brix said, it’s funded 13 research teams and developed an infrastructure to support suicide-related research programs and train the next generation of military suicide researchers.

Results of studies “will contribute to better screening, assessment, and treatment for those at risk for suicide,” Brix said.  

You also may be interested in...

DHA-PI 3200.01: Research and Development (R&D) Enterprise Activity (EA)

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (p): a. Establishes the Defense Health Agency’s (DHA) procedures for the Deputy Assistant Director (DAD), R&D to manage and execute, on behalf of the Assistant Secretary of Defense for Health Affairs (ASD(HA)), the portion of the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation assigned to it (referred to as the “DHP Science and Technology (S&T) Program)”. The DHP S&T Program includes Budget Activities (BAs) 6.1-6.3 and 6.6. The ASD(HA) provides policy, direction, and guidance to inform planning, programming, budgeting, and execution of the DHP RDT&E appropriation in accordance with statute, regulation, and policy in Reference (a). The DAD-R&D, and Component Acquisition Executive (CAE) manage and execute DHP RDT&E Program funds aligned to them on behalf of the ASD(HA). The CAE is responsible for managing BAs 6.4, 6.5, and 6.7 funding, as well as Procurement and Operations and Maintenance funding required to support DHP-funded Acquisition Programs, regardless of acquisition activity. b. Supports the Director, DHA, in developing appropriate DHA management models to maximize efficiencies in the management and execution of DHP RDT&E-funded activities carried out by the Combatant Commands (CCMDs), Services, Uniformed Services University of the Health Sciences (USU), Defense Agencies, and other DoD Components, as applicable. c. Codifies processes to confirm DHP RDT&E funds are applied towards medical priorities and aligned to ASD(HA) policy, direction, and guidance to develop and deliver innovative medical products and solutions that increase the readiness of the DoD medical mission in accordance with Reference (a). d. Supports the following objectives of the R&D EA: (1) Increasing the quantity, quality, and pace of medical research through improved programmatic organization, processes, and oversight. (2) Ensuring DHP RDT&E funded efforts align to ASD(HA) published program guidance that provides resourcing guidance and translates national, departmental, and Service priorities into specific program objectives. (3) Verifying alignment of DHP RDT&E funds to medical priorities and to ASD(HA) policy, direction, and guidance to ensure the development and delivery of medical materiel and knowledge solutions. (4) Facilitating coordination with the CCMDs, Services, USU, Defense Agencies, and other DoD Components, as applicable, to ensure DHP RDT&E funded activities address joint medical capability gaps, and avoid unnecessary duplication.

Guidance on the Establishment of a Human Cell, Tissue, and Cellular and Tissue Based Products Program

Policy

This memorandum requests the Services resource a Human Cell, Tissue, and Cellular and Tissue Based Products (HCT/Ps) Program that complies with regulatory standards for management and oversight of HCT/Ps, according to the best fit for their Service.

<< < 1 > >> 
Showing results 1 - 2 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing: Download a PDF Reader or learn more about PDFs.